^
Contact us  to learn more about
our Premium Content:  News alerts, weekly reports and conference planners
DRUG:

SCRI-CAR19x22v2

i
Other names: SCRI-CAR19x22v2, Patient-derived CD19- and CD22 specific CAR
Associations
Company:
Seattle Children's Hospital
Drug class:
CD19-targeted CAR-T immunotherapy, CD22-targeted CAR-T immunotherapy
Related drugs:
Associations